[Treatment of cystoid macular oedema according to Bangerter (author's transl)].
The biomicroscopic image of cystoid macular oedema was fully described by A. Bangerter in 1945. By means of fluorescein angiography additional cases may be revealed, but such cases are transitory and asymptomatic. Cystoid macular oedema seems to be caused by vascular disorders of inflammatory-toxic aetiology, the vitreous body being involved as a carrier of toxins. For treatment of cystoid macular oedema retrobulbar injections of vasodilators have been recommended by Bangerter. This therapy is definitely effective in cases of Irvine-syndrome, and in cases of cystoid macular oedema due to chronic iridocylitis, provided that application is starded early enough. Bangerter's treatment fails in other types of cystoid macular oedema. Corticosteroids are useful adjuvants, but they don't fully substitute Bangerter's treatment.
D006801:Humans; D008266:Macula Lutea; D010211:Papilledema / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D013577:Syndrome; D014606:Uveitis, Anterior / Q000150:complications; D014665:Vasodilator Agents / Q000008:administration & dosage
D014665:Vasodilator Agents
Die therapie des Zystoiden Makulaödems nach bangerter.